GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Daxor Corp (FRA:DX5) » Definitions » Debt-to-EBITDA

Daxor (FRA:DX5) Debt-to-EBITDA


View and export this data going back to 2021. Start your Free Trial

What is Daxor Debt-to-EBITDA?

Debt-to-EBITDA does not apply to banks.


Daxor (FRA:DX5) Business Description

Traded in Other Exchanges
Address
109 Meco Lane, Oak Ridge, TN, USA, 37830
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.